These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6448360)

  • 1. Plasmapheresis in multiple sclerosis: preliminary findings.
    Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
    Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis in multiple sclerosis: preliminary study.
    Weiner HL; Dawson DM
    Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. A pilot study.
    Khatri BO; Koethe SM; McQuillen MP
    Arch Neurol; 1984 Jul; 41(7):734-8. PubMed ID: 6234867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 8. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM; Shapshak P; Myers LW; Ellison GW; Tourtellotte WW; Lee M
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pancreatitis in systemic lupus erythematosus (SLE). Successful treatment with plasmapheresis after failure of prednisone.
    Zanen S; Brand A; Cats A
    Clin Exp Rheumatol; 1983; 1(4):341-4. PubMed ID: 6681151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis.
    Uccelli A; Capello E; Fenoglio D; Incagliato M; Valbonesi M; Mancardi GL
    Ital J Neurol Sci; 1994 Feb; 15(1):51-3. PubMed ID: 8206747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome.
    Dau PC; Denys EH
    Ann Neurol; 1982 Jun; 11(6):570-5. PubMed ID: 7114807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
    Losy J; Karolewska J; Wender M
    Neurol Neurochir Pol; 1996; 30(2):201-11. PubMed ID: 8756247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease.
    Dau PC
    J Neuroimmunol; 1990 Nov; 30(1):15-21. PubMed ID: 2229403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytoplasmapheresis in multiple sclerosis: preliminary laboratory findings.
    Ghezzi A; Zaffaroni M; Caputo D; Guaschino R; Gasco P; Montanini R; Cazzullo CL
    Ital J Neurol Sci; 1985 Mar; 6(1):85-7. PubMed ID: 3997466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange in multiple sclerosis.
    Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
    Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraproteinemia associated with demyelinating polyneuropathy or myositis: treatment with plasmapheresis and immunosuppressive drugs.
    Kiprov DD; Miller RG
    Artif Organs; 1985 Feb; 9(1):47-52. PubMed ID: 3994551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
    Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
    Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: current concepts and management.
    Arnason BG
    Hosp Pract (Off Ed); 1982 Feb; 17(2):81-9. PubMed ID: 6210614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.